Showing posts with label Impact 20/20. Show all posts
Showing posts with label Impact 20/20. Show all posts

Tuesday, September 23, 2014

BioProcess International (BPI) 2014 Announces Program Schedule for the New BPI Theater

The BPI Theater is specifically designed to give leading companies and scientific pioneers in biologics a platform to showcase their newest products, services and innovations that are driving the development of next-generation biologics.

“The BPI Theater is a exceptional opportunity for companies to stand out for the crowd and demonstrate their leadership and innovation,” said Elizabeth Cutler, Managing Director at IBC Life Sciences. “As the most significant event in the bioprocessing and manufacturing industry, we are committed to providing our delegates with the conference features, content and tools to maximize their ROI.”

The BPI Theater hosts interactive activities including live product demonstrations, interactive panel discussion, oral poster presentations and even more information-packed content. A vanguard of leading companies enabling the development of new biological products have already committed to launching their new products at the BPI Theater, including Pall Life Sciences, Asahi Kasei Bioprocess, Sartorius Stedim Biotech, Purolite Corporation, Meissner Filtration Products.

Additional BPI Theater programming includes the re-broadcasting of the selected keynote presentations, oral poster presentations, BioProcess International Awards recap, Impact 20/20 report update from the MassBio Association, strategic discussion and expert Q&A panel, prize announcements and more. See the full schedule here.

Additionally, new to BPI this year is partnering360®, a powerful tool for networking with potential partners. At BPI 2014 delegates gain exclusive access to a BPI specific partnering360® site, enabling them to identify and schedule meetings with potential partners, and foster deeper engagement before, during and following the event.

BioProcess International conference programming is held on October 20-23, two-day training courses on October 21-22, BPI Theater is open on October 22-23 and the exhibition is October 21-23.  As a reader of this blog, when you register to join us an mention code BPI14BLOG, you can save 20% off standard rates.


About IBC Life Sciences
IBC Life Sciences, a division of Informa, is your connection to the life sciences industry. Through conferences, webinars, podcasts and its suite of integrated marketing solutions, IBC Life Sciences delivers expert knowledge, valuable connections and customized offerings so customers can meet their goals. www.IBCLifeSciences.com


Share this article with your social network, just click below to share now!


Monday, September 22, 2014

What can Massachusetts do to keep their edge in the biopharmaceutical industry?

Mass Bio and Health Advances released the Impact 20/20 report earlier this year detailing how they believe Massachusetts could best keep their edge in innovation and technology in the innovation sector.  The report concluded that Massachusetts should bring value to the industry by bringing value to the health care industry and having a meaningful impact on patients lives.

They outlined the following four things to ensure the success of their industry:
  1. 1. Demonstrating Value 
  2. 2. Supporting Company Formation and Sustainability
  3. 3. Opportunities in Life Sciences Information Technology
  4. 4. Articulating the Patient Focus
The report also addresses the question of value of the Massachussetts healthcare cluster now that health care has changed with the implementation of Obamacare. Value created should be measured according to patients and what they receive - be an amplifier for the needs of each patient and figure out how to benefit them. The state needs to continue to work on ensuring a vibrant start up environment - have funding for innovative companies and affordable work space for them to conduct their research.

Read the full report here.

Peter Abair, Director of Economic Development & Global Affairs, MassBio and Sheela Hegde, Partner, Health Advances will be joining us in the BioProcess International Theater this October to dive in-depth on their findings and suggestions for the Massachusetts biotech sector.  We invite you to join us in the Innovation Theater on Wednesday, October 22 and Thursday, October 23.  Special rates are available for the Exhibit Hall.  Visit the pricing webpage to find out more and register.


Share this article with your social network, just click below to share now!